Daytime somnolence and night sleep disturbances in Parkinson's disease: Background and future treatment prospective

Angelo Antonini

doi:10.1007/s10072-007-0732-1

Daytime somnolence and night sleep disturbances in Parkinson's disease: Background and future treatment prospective

Angelo Antonini

Istituto di Neuroriabilitazione Motoria San Camillo

Research output: Contribution to journal › Article › peer-review

Abstract

Sleep abnormalities are common in patients with Parkinson's disease (PD). Current clinical evidence suggests that both daytime somnolence and night-time sleep abnormalities are related mainly to worsening disease. Improvements in drug delivery, such as transdermal patch, allow more stable dopaminergic stimulation throughout the day. This approach might prove beneficial also for nonmotor symptoms and particularly helpful in improving sleep architecture in PD.

Original language	English
Journal	Neurological Sciences
Volume	28
Issue number	SUPL.1
DOIs	https://doi.org/10.1007/s10072-007-0732-1
Publication status	Published - Jan 2007

Keywords

Daytime somnolence
Dopaminergic treatment
Parkinson's disease
Sleep abnormalities

ASJC Scopus subject areas

Clinical Neurology
Neuroscience(all)

Access to Document

10.1007/s10072-007-0732-1

Fingerprint Dive into the research topics of 'Daytime somnolence and night sleep disturbances in Parkinson's disease: Background and future treatment prospective'. Together they form a unique fingerprint.

Cite this

@article{ced5f75528c44783ba1d84033e6eeebc,

title = "Daytime somnolence and night sleep disturbances in Parkinson's disease: Background and future treatment prospective",

abstract = "Sleep abnormalities are common in patients with Parkinson's disease (PD). Current clinical evidence suggests that both daytime somnolence and night-time sleep abnormalities are related mainly to worsening disease. Improvements in drug delivery, such as transdermal patch, allow more stable dopaminergic stimulation throughout the day. This approach might prove beneficial also for nonmotor symptoms and particularly helpful in improving sleep architecture in PD.",

keywords = "Daytime somnolence, Dopaminergic treatment, Parkinson's disease, Sleep abnormalities",

author = "Angelo Antonini",

year = "2007",

month = jan,

doi = "10.1007/s10072-007-0732-1",

language = "English",

volume = "28",

journal = "Neurological Sciences",

issn = "1590-1874",

publisher = "Springer-Verlag Italia s.r.l.",

number = "SUPL.1",

}

TY - JOUR

T1 - Daytime somnolence and night sleep disturbances in Parkinson's disease

T2 - Background and future treatment prospective

AU - Antonini, Angelo

PY - 2007/1

Y1 - 2007/1

N2 - Sleep abnormalities are common in patients with Parkinson's disease (PD). Current clinical evidence suggests that both daytime somnolence and night-time sleep abnormalities are related mainly to worsening disease. Improvements in drug delivery, such as transdermal patch, allow more stable dopaminergic stimulation throughout the day. This approach might prove beneficial also for nonmotor symptoms and particularly helpful in improving sleep architecture in PD.

AB - Sleep abnormalities are common in patients with Parkinson's disease (PD). Current clinical evidence suggests that both daytime somnolence and night-time sleep abnormalities are related mainly to worsening disease. Improvements in drug delivery, such as transdermal patch, allow more stable dopaminergic stimulation throughout the day. This approach might prove beneficial also for nonmotor symptoms and particularly helpful in improving sleep architecture in PD.

KW - Daytime somnolence

KW - Dopaminergic treatment

KW - Parkinson's disease

KW - Sleep abnormalities

UR - http://www.scopus.com/inward/record.url?scp=33846499541&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33846499541&partnerID=8YFLogxK

U2 - 10.1007/s10072-007-0732-1

DO - 10.1007/s10072-007-0732-1

M3 - Article

AN - SCOPUS:33846499541

VL - 28

JO - Neurological Sciences

JF - Neurological Sciences

SN - 1590-1874

IS - SUPL.1

ER -